ArticleMolecular therapy : the journal of the American Society of Gene Therapy2019

A Potent Tumor-Reactive p53-Specific Single-Chain TCR without On- or Off-Target Autoimmunity In Vivo.

Hakim Echchannaoui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.